Segmed is proud to be sponsoring SCOPE for the first time, as a movement to support the clinical operations executives with our best-in-class solutions to access Real World Imaging Data (RWiD), providing greater availability of de-identified patient health data to support medical advancements towards better treatments and diagnostics. Come to see our solutions in a product demonstration with use cases and know more how we can offer tailored imaging datasets, approaching your research needs:
Unlock longitudinal oncology patient datasets for R&D
Enrich patient records with real-world imaging data
Multimodal datasets tailored to your research needs
De-identify your data with Segmed Incognito ... and more!
📅 Feb 11 - 14, 2024 📍 Booth 101
Segmed at SCOPE´24: Pioneering Innovation to Integrate Real World Data with Randomized Controlled Trials
SCOPE is the summit conference that fosters efforts to advance clinical trials and research, essential domains for advancing medical knowledge, improving patient care, and developing new treatments and therapies for the patients who need them.
Advancements in healthcare underscore the critical role of integrating RWD with RCT to enhance patient insights and research design. Despite challenges in accessing imaging RWD alongside sources like EMR, Segmed pioneers innovation in this area. We are making it possible to directly use image files & radiology reports, advancing RCT planning. This innovation accelerates progress in Life Science/MedTech, with the goal of swiftly developing new therapies and devices to benefit patients.
Plenary Session: Modernizing Trials with FDA & Intersection of Innovative Development Models and Investment Approaches
Come to this session and get to know how Segmed is pioneering innovation in healthcare. Despite challenges in accessing imaging RWD alongside sources like EMR, Segmed's is innovating in this area. Their breakthrough allows direct use of image files, not just radiology reports, advancing RCT planning.
Don't miss this session featuring our CDO and co-founder, Jie Wu!